Supplementary Data 1 from A novel class of Ribosome Modulating Agents (RMAs) exploits cancer ribosome heterogeneity to selectively target the CMS2 subtype of colorectal cancer
DOI:
10.1158/2767-9764.22795650
Publication Date:
2023-05-10T16:10:32Z
AUTHORS (13)
ABSTRACT
<p>ZKN-157- chemical characterization</p>
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....